Skip to search formSkip to main contentSkip to account menu

Recurrent Chronic Lymphoid Leukemia

Known as: CLL, relapsed, Recurrent Chronic Lymphocytic Leukemia, chronic lymphocytic leukemia, relapsed 
The reemergence of chronic lymphocytic leukemia after a period of remission.
National Institutes of Health

Related topics

Related topics

27 relations
Atypical lymphocyteB lymphoblastB-LymphocytesBCL3 gene

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Response to ibrutinib of refractory life-threatening autoimmune hemolytic anemia occurring in a relapsed chronic lymphocytic leukemia patient with 17p deletion
Autoimmune hemolytic anemia (AIHA) is one of the most common disease-specific complications of chronic lymphocytic leukemia (CLL… 
2016
2016
Idelalisib-induced pneumonitis
A woman in her 40s with relapsed follicular lymphoma presented with a few days history of shortness of breath and cough producing… 
2014
2014
A dose escalation feasibility study of lenalidomide for treatment of symptomatic, relapsed chronic lymphocytic leukemia.
2013
2013
Long‐term molecular remission with lenalidomide treatment of relapsed chronic lymphocytic leukemia
Lenalidomide is effective against relapsed chronic lymphocytic leukemia (CLL). We report the first case of long‐term molecular… 
2011
2011
Time to put the CAR-T before the horse.
In this issue of Blood , Brentjens and colleagues report on the feasibility, tolerability, and persistence of autologous CD19… 
Review
2010
Review
2010
Secondary cervical cancer in a patient with chronic lymphocytic leukemia and recurrent chronic lymphocytic leukemia mimicking recurrent cervical dysplasia: a case report.
BACKGROUND Patients with chronic lymphocytic leukemia (CLL) have up to a 3-fold risk of site-specific secondary cancers. The only… 
Review
2010
Review
2010
Standards for the treatment of relapsed chronic lymphocytic leukemia: a case-based study.
In recent years, considerable advances have been made in first-line treatment strategies for chronic lymphocytic leukemia (CLL… 
2008
2008
Flavopiridol (Alvocidib) Induces Durable Responses in Relapsed Chronic Lymphocytic Leukemia (CLL) Patients with High-Risk Cytogenetic Abnormalities
Background: Relapsed CLL patients (pts) with high-risk cytogenetic features have limited treatment options. Flavopiridol induces… 
2008
2008
Lumiliximab in combination with FCR for the treatment of relapsed chronic lymphocytic leukemia (CLL): results from a phase I/II multicenter study
7003 Background: Lumiliximab is an anti-CD23 monoclonal antibody that is being investigated for the treatment of relapsed B-cell… 
2001
2001
Combination Fludarabine, Cyclophosphamide, and Rituximab for Previously Treated Patients With Chronic Lymphocytic Leukemia
Treatment options for patients with relapsed chronic lymphocytic leukemia (CLL) are limited. In this report, we present our… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)